Hubert H. Fernandez, M.D.
Affiliations: | McKnight Brain Institute | University of Florida College of Medicine/McKnight Brain Institute, Gainesville |
Google:
"Hubert Fernandez"Mean distance: 106866
Collaborators
Sign in to add collaborator| Marcia H. Ratner | collaborator | 2005-2005 | University of Florida College of Medicine/McKnight Brain Institute, Gainesville |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fernandez HH, Macklin EA, Hauser RA, et al. (2023) Intrinsic auricular muscle zone stimulation for Parkinson disease: The EARSTIM-PD Phase II multi-center pilot study results. Parkinsonism & Related Disorders. 105959 |
| Vijayakumari AA, Fernandez HH, Walter BL. (2023) MRI-based multivariate gray matter volumetric distance for predicting motor symptom progression in Parkinson's disease. Scientific Reports. 13: 17704 |
| Vijayakumari AA, Mandava N, Hogue O, et al. (2023) A novel MRI-based volumetric index for monitoring the motor symptoms in Parkinson's disease. Journal of the Neurological Sciences. 453: 120813 |
| Alberts JL, Shuaib U, Fernandez H, et al. (2023) The Parkinson's disease waiting room of the future: measurements, not magazines. Frontiers in Neurology. 14: 1212113 |
| Fernandez HH, Odin P, Standaert DG, et al. (2023) Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum: Revelations from the MANAGE-PD validation cohort. Parkinsonism & Related Disorders. 105514 |
| Kundrick A, Hogue O, Namrow S, et al. (2023) Adopting a palliative care mindset is an unmet need in Parkinson's disease. Clinical Parkinsonism & Related Disorders. 9: 100206 |
| Antonini A, Odin P, Schmidt P, et al. (2021) Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications. Parkinsonism & Related Disorders. 92: 59-66 |
| Hauser RA, Hattori N, Fernandez H, et al. (2021) Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson's Disease: A Pooled Analysis of 8 Phase 2b/3 Trials. Journal of Parkinson's Disease |
| Salles PA, Mata IF, Fernandez HH. (2021) Should we start integrating genetic data in decision-making on device-aided therapies in Parkinson disease? A point of view. Parkinsonism & Related Disorders. 88: 51-57 |
| Isaacson SH, Ballard CG, Kreitzman DL, et al. (2021) Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients. Parkinsonism & Related Disorders. 87: 25-31 |